• Eating the right Food Determines your Health

    Eating the right Food Determines your Health

    CNN had an interview with Dr. Leana Wen about the fact that eating the right food determines your health. Dr. Wen is a wellness expert, an emergency physician and adjunct associate professor at George Washington University. How much does the quality of food we eat influence our health? There are detailed studies … [Read More...]

  • Regular Exercise Makes you 9 years younger

    Regular Exercise Makes you 9 years younger

    A recent publication noted that regular exercise makes you 9 years younger. The researchers meant that the biological age is 9 years younger than your chronological age. They went one step further and proved that regular exercise elongates your telomeres, which is why people who exercise regularly live longer. … [Read More...]

  • New Blood Test for Alzheimer’s Disease

    New Blood Test for Alzheimer’s Disease

    A recent study explained that a new blood test for Alzheimer’s disease is very reliable. Specifically, it determined with 96% accuracy elevated levels of beta amyloid. It also accurately identified tau protein, another Alzheimer’s marker, with 97%. The original research study was published at JAMA … [Read More...]

  • Living with the Aging Process

    Living with the Aging Process

    The following article describes living with the aging process. Older adults undergo the process of aging between the ages of 50 and 80. This is a complex process affecting various systems parallel. There are hormone factors that are particularly prominent in women during menopause. Joints are affected by … [Read More...]

  • Ashwagandha’s Benefits

    Ashwagandha’s Benefits

    Medical news today had an article in October 2023 that reviewed ashwagandha’s benefits. I thought it would be useful to discuss this topic in an abridged version. Often things get distorted on the Internet and a reality check helps to separate facts from fiction. Ashwagandha (botanical name: Withania somnifera) is a … [Read More...]

  • Beef and Dairy May Cause Cancer and MS

    Beef and Dairy May Cause Cancer and MS

    New cancer research suggests that chronic virus particles in beef and dairy may cause cancer and MS (multiple sclerosis). The Medical journal Medscape.com had a review article that summarized this line of research. Papillomaviruses and cervical cancer Harald zur Hausen, M.D., D.Sc., a German virologist, detected … [Read More...]

    Oct
    02
    2003

    Better Recovery From Strokes Through Early CT Scans

     Introduction

    You can have a better recovery from strokes through early CT scans. This was published in the September 2001 issue of the American Journal of Neuroradiology (Am J Neuroradiol – 01-SEP-2001; 22(8): 1534-42). A group of clinicians from the Foothills Hospital in Calgary/Alberta published an article with a scoring system for CT scans. These scans were done on every patient with a stroke. By utilizing early CT scans and this scoring system an ischemic stroke (due to a blood vessel that closed off in the brain) could be rapidly assessed.

    Early CT scan helps to decide whether clot-busting drugs help the patient

    Within 3 hours of the beginning of the stroke the treating physician would know whether the patient would benefit from clot-busting drugs (TPA or tissue plasminogen activator) or not. Dr. Pexman and co-workers had noted that patients with an Alberta Stroke Program Early CT Score (ASPECTS) of less than 7 had a poor survival rate or an outcome with high dependency on caregivers. Patients with a score of 7 to 10 had a much better survival chance and were ideal candidates for the clot-busting therapy. The radiologist who reads the CT scan of the brain of the stroke patient divides th CT scan into 10 regions. Researchers evaluate the findings systematically and obtain an ASPECTS score.

    Ischemic strokes treated early

    Dr. Michael Hill, an assistant professor at the University of Calgary, and one of the co-workers of this initial study has now completed a further follow-up study together with Dr. A.Buchan, director of the Calgary Stroke Program. The authors published the results of the study in the August 2003 issue of the medical journal “Stroke”. They found that ischemic strokes (from clots in the middle cerebral artery) have the best outcome when detected by CT scan early (within 3 hours of the beginning of the stroke) and if thrombolysis therapy with TPA, the clot-busting drug, is done before 6 hours after the beginning of the stroke.

    Better Recovery From Strokes Through Early CAT Scans

    CT Scan of Ischemic Stroke

    Stroke in the middle cerebral artery diagnosed early

    The lack of blood circulation from a stroke, which closed the middle cerebral artery, is shown in this link. What does that mean in practical terms? Let us assume a patient is suddenly losing all of the strength and movement in one arm and losing speech as well. In this case the physician orders an emergency CT scan right away. This helps to determine that the patient had a stroke in the middle cerebral artery region. Let us say that the ASPECTS score was between 7 and 10. This patient’s physicians would likely treat the stroke with the clot-busting medicine mentioned being confident that there likely will be a good outcome.

    Less permanent palsies with early intervention 

    Before this therapy was available, many of these patients ended up with a permanent arm palsy without much function. They likely also sustained a permanent speech deficit as well. After the clot-busting therapy many of these patients have a much better outlook. Now they have a considerably better return of function in their arm and regain their speech as well. Unfortunately, the opposite is true as well.

    Those with an ASPECTS score below 7 do poorly with their stroke

    Those with a poor ASPECTS score below 7 will not be candidates for the clot-busting therapy. They tend to do poorly. Several countries use this scoring system of early CT scans already to investigate the severity of strokes (ASPECTS). Among those are Canada, the US, Australia and Europe.  Dr. A.Buchan said: “Early detection and intervention in stroke is critical to achieve a positive outcome”. He is the director of the Calgary Stroke Program. In addition, he is also a professor in the department of clinical neurosciences of the University of Calgary/Alberta. Here is a link for more background on strokes.

    Sep
    01
    2003

    West Nile Virus (WNV) Vaccine Being Tested In Humans

    According to Dr. Tom Monath, the scientific officer of the Acambis pharmaceutical company, human trials on a new vaccine for West Nile virus (WNV) can begin as soon as the FDA will give the green light (likely in October of 2003).

    At the 2003 World Vaccine Conference in Montreal/Canada this summer Dr. Monath explained that Acambis has been doing research for a new vaccine against WNV since 1999 when this virus arrived in New York. The virus belongs into the same group of flaviviruses as dengue fever, yellow fever and Japanese encephalitis.

    Yellow fever has been successfully prevented by vaccination with a live vaccine that has been modified considerably (called 17D attenuated vaccine). This strain is basically a harmless virus, which will induce a strong immune response in 100% of vaccinated people. If this is repeated every 10 years, a vaccinated person would be safe to travel in yellow fever infested areas. Based on this knowledge the researchers of Acambis have created a chimera virus where the yellow fever vaccine (attenuated virus 17D) is used as a vehicle in the center while the surface has been modified by incorporating parts of the WNV into its envelope. As this new vaccine virus has qualities of both the yellow fever vaccine virus and the WNV, it is called a chimera virus. The same technology has already been successfully applied to two other flavivirus vaccines, namely the dengue fever vaccine and the Japanese encephalitis vaccine.

    West Nile Virus (WNV) Vaccine Being Tested In Humans

    West Nile Virus (WNV) Vaccine Being Tested In Humans

    The new WNV vaccine has been tested extensively in mice and monkeys and has been found sofar to be very safe and it is mounting a very good immune response. It is timely that human trials are being done now starting this fall as WNV seems to be expanding rapidly throughout the United States and Canada. The vaccine would be needed particularly for older people as in them the WNV disease presents much more violently with a higher death rate. However, visitors from Europe to the US and Canada will likely want to protect themselves as well before they travel.

    Comment in July 2012: A vaccine for humans is still not available, for horses it is.

    Last edited December 9, 2012

    Sep
    01
    2003

    Stillbirth Associated With High Coffee Consumption In Pregnancy

    A study entitled “Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life” by Dr. K. Wisborg et al. was published recently in the British Medical Journal (BMJ 2003; 326: 420-423).

    The pregnancy outcome of 18,478 women who completed a questionnaire at their first prenatal visit was studied. They were asked about coffee consumption and the following 4 groups were identified: group 1 consisted of the 43% of women who drank no coffee. Group 2 (34%) drank 1-3 cups per day, group 3 drank 4-7 cups per day (18%). Group 4 drank 8 or more cups per day (5%).

    Below are the results in tabular form.

    The surprising result was that a small amount of coffee (1-3 cups per day) was actually reducing the risk of stillbirth by 30% when compared to women who drank no coffee at all. However, from 4 cups of coffee per day or more there was a sharp increase of stillbirths within the first year (=sum of stillbirths and deaths within the first year of life).

    Stillbith Associated with High Coffee Consumption in Pregnancy

    Stillbith Associated with High Coffee Consumption in Pregnancy

    The authors suggest that physicians should advise their pregnant patients to limit coffee consumption in pregnancy to 1 or 2 cups of coffee or the equivalent of caffeinated drinks per day as a precautionary measure.

    Stillbirth coffee study
    Groups with varying amounts of coffee consumption: Risk increase of stillbirth compared to group 1 as control:
    group 2  (1- 3 cups per day) -30%
    group 3 (4 – 7 cups per day) 80%
    group 4 (8 or more cups per day) 300%

    Last edited December 9, 2012

    Sep
    01
    2003

    Asthma And Wheezing Influenced By Family Lifestyle (Swedish Study)

    A new study from Sweden was published by Dr. Magnus Wickman and colleagues,from the Karolinska Hospital in Stockholm, in the medical journal Allergy 2003;58:730-731,742-747. The authors of this study were analyzing data of a prospective birth cohort study of 4089 children who were born in Sweden between 1994 and 1996.

    The families were given health questionaires at the age of 2 months to assess whether the family was adhering to the allergy prevention guidelines (see below). Questionaires were again given at the age of 1 year and 2 years of these children. Specific questions were asked regarding environmental conditions in the house where the children lived. In the mid 1990’s allergy prevention guidelines were strongly recommended to the public in Sweden regarding the value of breast feeding, the avoidance of smoking inside the house in the presence of children, also that a house should be kept well ventilated and without dampness. All of these factors, as was stressed by the allergists in Sweden who organized the campaign, would protect the immune system from allergies against molds, dust mites as well as cigarette smoke and should reduce the rates of asthma.
    Here are the results in tabular form.

    Asthma And Wheezing Influenced By Family Lifestyle (Swedish Study)

    Asthma And Wheezing Influenced By Family Lifestyle (Swedish Study)

    As can be seen from this table, which is based on families without allergic parents, a two-fold drop of asthma and wheezing occured when the allergy prevention guidelines were followed in the house. With allergic parents the children had an even greater benefit as the reduction of asthma and wheezing was three-fold when compared to controls who did not follow the guidelines. This is one of the few studies, which shows conclusively that allergy prevention works!

    Link to asthma chapter of Dr. Schilling’s Net Health Book: http://nethealthbook.com/lung-disease/asthma-introduction/

    Swedish Family Lifestyle Study
    Agreement with
    allergy guidelines
    % of asthma and wheezing at ages 1 and 2 of child:
    1
    year
    2
    years
    Yes (all three measures followed) 6.8% 12.6%
    No (one or none of measures followed) 17.9% 24.1%

    Last edited October 26, 2014

    Sep
    01
    2003

    SARS Due To SARS-Associated Coronavirus (SARS-CoV)

    A comprehensive paper was recently published online July 22, 2003 (Lancet 2003; 362: 263-70) regarding the causative microorganism of SARS.

    Several investigators have collaborated in this study from viral laboratories of Rotterdam/The Netherlands, Hong Kong Special Administrative Region/China , Singapore, London/UK, Hamburg/Germany, Paris/France and Geneva/Switzerland.

    This study involved isolation of the SARS-associated coronavirus (SARS-CoV) from SARS patients who died from the disease, propagation of the virus in an experimental animal model (cynomolgus macaques) and causing SARS again with an injection of the isolated virus back into a healthy experimental animal.

    This, according to the authors (Dr. Thijs Kuiken et al.), fulfils the Koch’s postulates, which is one of the fundamental laws in microbiology that has to be fulfilled in order to claim a new infective organism. Dr. Robert Koch was a German physician who had detected the causative organisms of anthrax, tuberculosis and cholera and won the Nobel price for physiology and medicine in 1905. He developed the four original Koch’s postulates that were subsequently modified to a total of six. Here is a run down of the postulates and how it relates to SARS:

    SARS Due To SARS-Associated Coronavirus (SARS-CoV)

    SARS Due To SARS-Associated Coronavirus (SARS-CoV)

    1. The specific organism should be present in all cases of animals suffering from a specific disease, but should not be found in healthy animals.

    For SARS this was fulfilled as this study, which was based on a thorough analysis of 436 patients in six countries, showed. 75% of the suspected cases were found in postmortem studies to contain the SARS-associated coronavirus (SARS-CoV). In some patients other infectious agents could also be isolated, but the primary causative agent was SARS-CoV.

    2. The specific organism should be isolated from a diseased animal and grown in pure culture on artificial laboratory media.

    Using an experimental animal model, the virus was able to be isolated from a diseased person and injected into a healthy animal that turned sick with SARS. From this animal the virus could be isolated again from cells of the infected airways and grown in tissue culture.

    3. This freshly isolated microorganism, when inoculated into a healthy laboratory animal, should cause the same disease as in the original animal.

    As already explained under point 2 above, this has been shown with SARS.

    4. The microorganism should be able to be isolated again in pure culture from the experimental infection.

    This was proven in this paper regarding SARS. It was even done with genetic markers that were still present after passage from postmortem human tissue into an experimental animal and from the final respiratory tissue isolate of this newly infected animal.

    5. The infective agent can be filtered and the filtrate contains the infective agent.

    This was proven for SARS and the exact classification of the virus was possible because of the advanced genetic knowledge that is now available.

    6. When the virus enters the body or the experimental animal, there are signs of the immune system attempting to rid the body of the infectious organism.

    Sophisticated immune tests were performed that showed in more than one way that the immune system attempted to rid the body of SARS, but was eventually overwhelmed in the cases that did not survive.

    Summary: This paper has conclusively proven that SARS is caused by a new type of coronavirus, SARS-associated coronavirus (SARS-CoV). In about 12% of cases there was another virus type present, such as human metapneumovirus. This occasionally was also present in lethal SARS cases as a secondary virus. Some other flu-type viruses were also found in the non-SARS cases. However, this paper has shown that SARS-associated coronavirus (SARS-CoV) is what causes SARS.

    Link to SARS chapter of Dr. Schilling’s Net Health Book: http://nethealthbook.com/infectious-disease/infectious-disease-infections/severe-acute-respiratory-syndrome/

    Last edited October 26, 2014

    Sep
    01
    2003

    Poor Lungs And Heart Attacks Related To Leptin Levels

    It is known from the medical literature that poor lung function can often lead to heart attacks making it one of the important causes of premature death for patients with poor lungs (due to emphysema, chronic bronchitis, COPD etc.).

    A research team led by Dr. Don Sin from the University of Alberta, Edmonton, Canada, asked the question recently whether there may be a circulating factor that would be responsible for this association of poor lung function and increased cardiovascular disease.

    They studied serum leptin and a variety of other inflammatory markers such as C reactive protein, leukocytes, and fibrinogen in 2808 participants in the Third National Health, Nutrition, and Examination Survey. Apart from blood tests they also measured lung function by spirometry (forced expiratory volume in 1 second, called FEV1). The leptin levels found in these patients were then divided into 5 groups from low to high levels. They also carefully adjusted the data for body mass index, sex, age and other factors. They compared the group with the lowest leptin concentration (lowest quintile) with the highest group of leptin concentration (highest quintile) and looked for any significant differences in any of the markers.

    Results: The highest quintile group (high leptin in blood samples) had also the highest other inflammatory markers in their blood (C-reactive protein, leukocytes and fibrinogen). This group was the one that was associated with advanced lung diseases as well as heart disease. The authors of this study, which was recently published in a medical journal (Thorax 2003;58:695-698), concluded that leptin plays an important role, if not the major role, in the development of both chronic lung disease and cardiovascular complications.

    Poor Lungs And Heart Attacks Related To Leptin Levels

    Poor Lungs And Heart Attacks Related To Leptin Levels

    Links to lung disease: http://www.nethealthbook.com/articles/chronicobstructivepulmonarydisease.php
    Links to heart attacks:

    http://www.nethealthbook.com/articles/cardiovasculardisease_heartdisease.php

    Last edited December 9, 2012

    Aug
    01
    2003

    Newly Detected Hormone May Help Obesity

    At a recent meeting of the Endocrine Society in Philadelphia new findings by British researchers were presented regarding hormone interactions with weight problems.

    Dr. Simon Aylwin, a consultant from the King’s College Hospital in London, England, presented data showing that peptide hormone PYY levels were much lower in patients who were significantly obese versus normal weight controls.

    As Dr. Stephen Bloom’s research group from Imperial College, London, UK had shown earlier, with a meal rich in calories the gut produces the PYY hormone in a way that with higher amounts of calories in food consumed more of the hormone PYY is secreted into the blood stream. The new information that was discussed at the meeting of the Endocrine Society was the fact that these hormone signals are registered in the hypothalamic tissue, a part of the brain situated just above the pituitary gland. It has been known for a long time that weight is regulated by a satiety centre in the hypothalamus. Now it has been appreciated that there are at least two or more pathways of registering weight related hormone signals: one being the gut related PYY hormone that tells the brain that enough food was consumed in a meal, and secondly leptin hormone signals where the hormone leptin is secreted from the fatty tissues in the body, which tells the satiety centre of the brain that not as much food needs to be consumed when our weight has reached a certain threshold.

    Newly Detected Hormone May Help Obesity

    Newly Detected Hormone May Help Obesity

    Dr. Aylwin measured PYY hormone levels in a number of different groups of patients such as in patients who were obese, in patients who had gastric bypass surgery done and in a group who only had gastric banding done. They observed that the group who had bypass surgery done had a higher than normal response of PYY hormone release as a response to a meal. This enabled them to adhere to low calorie meals without any hunger pangs and this group of patients did well in terms of weight control on the longterm.

    In contrast to this the group with gastric banding had a flat response curve to the stimulus of a meal with respect to the PYY hormone as did patients with obesity. The low PYY levels in response to meals likely explains why these patients continue to eat too much making their weight loss efforts more difficult.

    Dr. Aylwin explained that with future research efforts new forms of medications could be developped that mimic the effects of the PYY hormone leading to satiety and allowing patients to control their weight easier. Dr. Linda Fish, an endocrinologist from the University of Minnesota, mentioned that for excessive obesity with a body mass index of more than 45 the only effective therapy right now would be the invasive gastric bypass procedure. With an anologue type medication that would have the same effect as the PYY hormone, many patients might be able to have persistent weight loss with these new medications allowing them to lose weight persistently without bypass surgery. However, results of this type of research likely would take about 10 years before a new drug would be available to the public.

    This summary is based on an article in the July 15, 2003 issue of the Medical Post (page 50) as well as on the newsdesk article entitled “Obesity-is it all in the mind?” in The Lancet Neurology Volume 2, Number 1, January 2003.
    Link to related topic (nasal spray for obesity).

    Last edited December 9, 2012

    Aug
    01
    2003

    Modify Risk Factors For Erectile Dysfunction (ED) In Elderly Men

    Erectile dysfunction (ED, impotence) is a subject that is difficult to research because of its personal nature. Very few good studies are available regarding the question as to how common it would be among older men.

    A team of medical experts under Dr. Constance G. Bacon from the Harvard School of Public Health and other institutions have investigated this problem in men older than 50 years and published the results in the August 5, 2003 issue of the Annals of Internal Medicine.

    31,724 men aged 53 to 90 years were taking part in the Health Professionals Follow-up Study. Since 1986 they had been filling out detailed questionaires biennially. In 2000 detailed questions about sexual function were also included. Erectile dysfunction was defined as “having poor or very poor ability to have and maintain an erection sufficient for intercourse without treatment during the past 3 months”. The investigators found that about 1/3 of the men above the age of 50 had a sexual dysfunction. Such factors as orgasm, ability to have intercourse, sexual desire and overall sexual function were all affected more and more with every year after the age of 50. When this was further analyzed using multivariate analyses an interesting pattern of reasons for this emerged. The following factors were identified to be independent risk factors for the development of erectile dysfunction.

    Modify Risk Factors For Erectile Dysfunction (ED) In Elderly Men

    Modify Risk Factors For Erectile Dysfunction (ED) In Elderly Men

    Each of the factors from this table is an independent risk factor and can be managed separately. For instance, the investigators found that a higher level of physical activity was associated with much less ED. The best group (men with no ED) was found among those who were always conscious about disease prevention and who had none of the conditions listed in this table or other chronic medical conditions. Leanness and physical activity were associated with good sexual functioning in this study.

    Risk factors leading to erectile dysfunction (ED)
    Symptoms: Comments:
    increasing age
    aging likely affects the blood supply to the swelling bodies of the penis; it also clamps down on testosterone production of the testicles
    smoking accelerates aging and hardening of arteries
    diabetes mellitus affects circulation and nerve impulse transmission
    stroke
    interferes with brain centers of arousal
    antidepressant medication anticholinergic side-effect interferes with penile erection
    beta-blocker medication reduction of libido (likely at the brain level from sympathetic nerve block)
    alcohol consumption alcohol is a nerve poison that interferes with pudendus nerve function (lack of erections)
    TV viewing time due to prolonged sitting there is a chronic lack of exercise that leads to nerve conduction and circulatory problems resulting in ED

    This summary is based on a paper published in the medical journal of Annals of Internal Medicine 2003;139:161-168 by Dr. Constance G. Bacon and co-workers.

    Here is a brief chapter on erectile dysfunction from Dr. Schilling’s web-based free Net Health Book.

    Last edited October 26, 2014

    Aug
    01
    2003

    HRT; Findings From The British Million Women Study

     

    In the latest issue of the Lancet (Lancet 2003;362:414-415,419-427) a study from Great Britain was published regarding the risk of breast cancer. Over 1 million women were followed from 1996 to 2001. They were in the age group of 50 to 64. Of these 80% were postmenopausal, and these formed the basis of the study. Dr. Valerie Beral (from the Cancer Research group UK in Oxford) was the lead investigator. About half of the women were on various forms of hormone replacement therapy (HRT), the others were not and served as a control. Risks were always expressed in comparison to the controls without any hormone replacements. Here is a tabular summary of the various hormone replacement therapies and their risks of leading to breast cancer.

    The relative risk of developing breast cancer did not significantly change whether HRT was taken orally, transdermally or through implanted formulations. Tibolone is a synthetic steroid used for postmenopausal symptoms and treatment of endometriosis.

    Dr. Beral’s group has estimated that in Great Britain in the past 10 years about 20,000 additional cases of breast cancer were caused by HRT for menopause among women aged 50 to 64. Out of these about 75% were due to the use of the combination of estrogen/progestin.

    HRT; Findings From The British Million Women Study

    HRT; Findings From The British Million Women Study

    An accompanying editorial by Dr. Chris van Weel stated that “general practitioners should discourage HRT for their patients” and, if used, should last “no longer than 3-6 months”. The investigators of this study suggested that “discontinuing HRT should be suggested in as supportive a way as possible, because no one will benefit from panic or over-reaction”.

    Findings from the British Million Women Study on HRT
    Detail of hormone replacement: Breast cancer risk compared to control:
    overall risk of HRT for all groups of HRT 1.66-fold
    women who stopped HRT the previous year 1.14-fold
    estrogen only use currently 1.30-fold
    estrogen-progestagen combination
    1.88-fold
    tibolone users
    1.45-fold
    combination HRT user less than 5 years 1.7-fold
    combination HRT user more than 5 years 2.21-fold
    equine estrogen combined with medroxyprogesterone acetate and taken at least 5 years 2.42-fold
    death rates from breast cancer associated with current use of HRT 1.22-fold

    Discussion: Please keep in mind that the British authors of this study were using the drug manufactured synthetic hormone-like substances and NOT bio-identical hormones. The outcome with bio-identical hormones would have shown the opposite, namely that women would not have developed heart attacks, strokes or cancer and they would not have died prematurely. Read more about bio-identical hormone replacement in the links below.

    Here is a link to a chapter on menopause from Dr. Schilling’s Net Health Book.

    This link deals with bioidentical hormone replacement (see lower half of that page).

    Last edited October 26, 2014

    Aug
    01
    2003

    Reduction Of Complications After A Stroke

    Following an acute stroke, it used to be taught in medical school that lowering the blood pressure would be something to avoid for fear that this would lower circulation to the brain and could make a stroke worse. A new study, called ACCESS (Acute Candesartan Cilexitil Therapy in Stroke Survivors), is proving this teaching wrong and demands a 180° turnaround.

    Dr. Joachim Schrader has pablished this landmark study recently in the Medical Journal “Stroke” (Stroke – 01-JUL-2003; 34(7): 1699-703). This study followed 339 stroke patients after an initial angiotensin type 1 receptor blocker was given right away versus a control group who got it only 1 week later. In other words, the test here was to see what would happen, if treatment would be started right away during the acute phase of the stroke. Up to now this was only done in the stable period after 1 or 2 weeks (the conventional approach). The 1 year follow-up data showed that the overal death rate from all causes (summing up all complications) was 47.5% less in the treatment group than in the control group. In other words by using intervention with this newer type of blood pressure lowering medication, such as the angiotensin type 1 receptor blocker candesartan (Atacand), complications such as extension of the stroke or heart problems and other complications were averted. The end result were fewer deaths and better quality of life in those who survived.

    The Medical Post in its July 29, 2003 edition (p. 1 and 54) interviewed Dr.Ashfak Shuaib, professor of neurology of the University of Alberta in Edmonton, regarding the significance of this study. He felt that there likely would be a new hormonal effect on the brain from the lining of the arteries in the brain that gets blocked and that leads to an increase of blood supply to the brain.

    Reduction Of Complications After A Stroke

    Reduction Of Complications After A Stroke

    This in turn would rescue the brain tissue around the stroke preventing the late complications. He said that this line of research would be very solid data, but that it would have to be confirmed by an independent study from other investigators. Dr. Shuaib’s group of researchers are planning an imaging study where they will study the blood flow following strokes under the same conditions using candesartan (Atacand).

    Link to a chapter on stroke of the Net Health Book.

    Last edited October 26, 2014